.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Accenture
McKinsey
Merck
Deloitte
Cerilliant
Express Scripts
Dow
Teva
Moodys
Cantor Fitzgerald

Generated: December 16, 2017

DrugPatentWatch Database Preview

Drug Master Files for: glucagon

« Back to Dashboard


DMF No. Status Type Submission Date Holder Subject
2961III6/7/1977NOVO NORDISK ASGLUCAGON (BULK)
3738III3/14/1980NOVO NORDISK ASZINC PROTAMINE GLUCAGON NOVO, PREPARATION AND PACKAGING DOSAGE FORMS
5546III9/20/1984DIOSYNTH BVGLUCAGON
7773III10/31/1988IAF BIOCHEM INTERNATIONAL INCSYNTHETIC GLUCAGON HYDROCHLORIDE HUMAN
8253III10/19/1989BACHEM FINE CHEMICALS INCGLUCAGON (1-29), HUMAN HCl SALT - TORRANCE AND SAN DIEGO, CA.
10613III12/10/1993PENINSULA LABS INCGLUCAGON-LIKE PEPTIDE 1 (7-36)
11110III9/30/1994BACHEM INCGLUCAGON-LIKE PEPTIDE (7-37)
12297III12/27/1996BACHEM CALIFORNIAGLUCAGON (1-29), HUMAN
13906III12/22/1998RESTORAGEN INCRECOMBINANT GLUCAGON-LIKE PEPTIDE-1 (RGLP)
18277AII4/12/2005BACHEM AGGLUCAGON
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.


Drug Master File Glossary

STATUS OF DMFS

  • A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
  • I = Inactive
  • N = Not an assigned number
  • P = DMF Pending Filing Review

TYPES OF DMFs

  • Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
  • Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
  • Type III Packaging Material
  • Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
  • Type V FDA Accepted Reference Information

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Merck
Cantor Fitzgerald
McKesson
US Department of Justice
Queensland Health
AstraZeneca
Daiichi Sankyo
QuintilesIMS
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot